+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Genome Analysis Kits Market - Global Forecast 2026-2032- Product Image
Targeted Genome Analysis Kits Market - Global Forecast 2026-2032- Product Image
Sale

Targeted Genome Analysis Kits Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122186
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Targeted Genome Analysis Kits Market is projected to reach USD 3.06 Billion in 2026. It is expected to continue growing at a CAGR of 6.46%, reaching USD 4.48 Billion by 2032.

Targeted Genome Analysis Kits: Executive Overview

Targeted genome analysis kits support focused examination of predefined genomic regions, helping laboratories investigate selected genes, variants, or biological pathways without sequencing an entire genome. Their use spans research, translational science, inherited-disease studies, oncology, infectious-disease investigations, and other applications where analytical focus, workflow efficiency, and manageable data volumes are important.

Adoption is shaped by assay design, sample quality, sequencing compatibility, informatics requirements, laboratory expertise, regulatory expectations, and access to validated workflows. Buyers increasingly evaluate complete solutions rather than individual reagents, including library preparation, enrichment, quality control, interpretation, and technical support.

How Workflow Integration and Precision Are Reshaping the Landscape

The landscape is shifting from standalone kit procurement toward integrated, application-specific workflows. Laboratories are placing greater emphasis on reproducibility across sites, compatibility with established sequencing platforms, automation readiness, simpler sample preparation, and transparent quality-control procedures.

At the same time, demand is becoming more specialized. Panels are being tailored to disease areas, pharmacogenomics, population studies, and pathogen surveillance, while researchers seek broader variant coverage without sacrificing manageable analysis. Regulatory documentation, analytical validation, data governance, and interoperability are also becoming central purchasing considerations, particularly for clinical and public-sector laboratories.

Artificial Intelligence Is Accelerating Interpretation and Workflow Decisions

Artificial intelligence is influencing targeted genome analysis primarily through data interpretation, quality assessment, prioritization, and workflow optimization. Machine-learning methods can help identify technically weak samples, classify sequencing artifacts, prioritize variants for review, and connect genomic findings with curated clinical or biological evidence.

The cumulative impact depends on data quality and governance. AI-supported tools require representative training data, explainable outputs, controlled validation, cybersecurity safeguards, and clear human oversight. They can reduce repetitive review and support faster decisions, but they do not remove the need for laboratory confirmation, expert interpretation, or compliance with applicable privacy and clinical standards.

Regional Insights: Infrastructure and Regulatory Context Shape Adoption

North America benefits from mature sequencing infrastructure, strong biomedical research capacity, and established laboratory networks, while procurement increasingly emphasizes validation, interoperability, and clinical workflow integration. Latin America presents opportunities linked to public-health surveillance, academic research, and expanding molecular-testing capacity, although import procedures, funding variability, and uneven infrastructure can affect access.

Europe is characterized by sophisticated research and healthcare systems, cross-border data considerations, and strong attention to privacy, quality management, and diagnostic validation. The Middle East is developing genomics capabilities through national health initiatives and specialized research programs, with workforce development and local infrastructure remaining important. Africa has significant needs in infectious-disease surveillance, population genomics, and diagnostic strengthening, but adoption is influenced by affordability, supply continuity, laboratory capacity, and data sovereignty.

Asia-Pacific combines advanced genomics ecosystems in several markets with rapidly expanding capabilities elsewhere. Investment in precision medicine, biobanking, translational research, and public-health genomics supports demand, while differences in reimbursement, regulation, technical expertise, and access to maintenance services create varied implementation conditions.

Group Insights: Economic and Security Alliances Influence Genomics Priorities

ASEAN countries are developing genomics capacity through collaborative research, public-health programs, and expanding laboratory networks, with procurement often shaped by affordability, training, and regional interoperability. BRICS members show diverse priorities spanning population health, infectious-disease research, agricultural or environmental applications, and domestic scientific capability.

The European Union emphasizes cross-border research coordination, privacy, laboratory quality, and harmonized standards, while G7 members generally combine advanced research infrastructure with demanding validation and data-governance expectations. GCC countries are strengthening precision-health programs and centralized laboratory capabilities, creating interest in scalable workflows and specialist training. NATO members may also evaluate targeted genomic tools in relation to biosurveillance, health security, preparedness, and resilient laboratory supply chains, subject to civilian and national regulatory requirements.

Country Insights: National Capacity Creates Distinct Adoption Conditions

Australia and Canada combine strong research institutions with geographically distributed healthcare systems, making workflow standardization, logistics, and remote support important. The United States has broad academic, clinical, and biotechnology capacity, with purchasing decisions strongly influenced by validation, interoperability, reimbursement context, and regulatory documentation.

Brazil and Mexico are expanding molecular and genomic capabilities, while public-sector procurement, workforce development, import logistics, and regional access remain important considerations. China is building extensive domestic genomics and research capacity, with emphasis on local infrastructure, data governance, and application-specific development. India is advancing genomics through research, diagnostics, and public-health initiatives, while affordability, training, and scalable laboratory operations remain central.

France, Germany, Italy, Spain, and the United Kingdom have established research and healthcare ecosystems, with demand shaped by laboratory quality systems, privacy obligations, clinical evidence, and integration with national or regional health structures. Japan and South Korea emphasize precision medicine, advanced diagnostics, automation, and high-quality manufacturing or research workflows. Russia’s adoption environment is influenced by domestic scientific capacity, supply-chain resilience, regulatory conditions, and access to specialized equipment and reagents.

Recommendations for Leaders: Build Validated, Flexible, and Supportable Workflows

Industry leaders should design kits around clearly defined applications, transparent performance specifications, and compatibility with widely used sequencing and laboratory systems. Product development should prioritize reproducibility, automation, sample-type flexibility, robust quality controls, and documentation that supports analytical validation across different laboratory settings.

Commercial and operational strategies should account for regional differences in regulation, infrastructure, procurement, and technical expertise. Local training, dependable distribution, service support, and modular informatics can improve implementation. Leaders should also establish responsible AI governance, including validation procedures, auditability, cybersecurity, privacy protection, and explicit requirements for expert review.

Finally, organizations should engage laboratories, clinicians, researchers, public-health agencies, and regulators early. Co-development and pilot programs can reveal workflow constraints, strengthen evidence packages, and help ensure that targeted panels remain clinically or scientifically relevant as variant knowledge evolves.

Research Methodology: Evidence-Based Assessment of Market Dimensions

This executive summary uses the defined market scope of targeted genome analysis kits and evaluates adoption through a qualitative synthesis of application requirements, workflow characteristics, technology developments, infrastructure conditions, regulatory considerations, and regional implementation factors. The assessment distinguishes product capabilities from broader laboratory and healthcare-system readiness.

Regional, group, and country observations are organized around documented differences in genomics infrastructure, research activity, public-health priorities, data governance, procurement environments, and technical capacity. Artificial intelligence is considered as an enabling layer for quality control, interpretation, and workflow management rather than as a substitute for laboratory validation. No market estimates, market shares, forecasts, or company-specific claims are included.

Conclusion: Targeted Analysis Gains Value Through Integration and Trust

Targeted genome analysis kits occupy an important role between narrowly focused testing and comprehensive genomic investigation. Their value is strongest when assay design, laboratory processes, sequencing compatibility, informatics, interpretation, and quality management operate as a coherent workflow.

Future progress will depend less on panel breadth alone and more on reliable performance, adaptable design, responsible AI support, skilled users, secure data practices, and fit with regional healthcare and research systems. Organizations that combine technical rigor with strong implementation support will be better positioned to translate targeted genomic data into reproducible scientific, clinical, and public-health outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Targeted Genome Analysis Kits Market, by Target Type
7.1. Introduction
7.2. DNA
7.2.1. Germline DNA
7.2.2. Somatic DNA
7.2.3. Mitochondrial DNA
7.3. RNA
7.3.1. mRNA
7.3.2. Non-Coding RNA
7.3.3. Fusion Transcripts
7.4. Epigenetic Marks
7.4.1. DNA Methylation
7.4.2. Chromatin Accessibility
8. Targeted Genome Analysis Kits Market, by Product Type
8.1. Introduction
8.2. Complete Kits
8.2.1. Library Preparation Kits
8.2.2. Target Enrichment Kits
8.2.3. Integrated Library and Enrichment Kits
8.3. Panel-Only Reagent Sets
8.4. Accessories and Controls
8.4.1. Indexing and Barcoding Kits
8.4.2. Reference Standards and Controls
8.4.3. Cleanup and Size Selection Reagents
8.5. Software and Analytics Bundles
8.5.1. Data Analysis Software Licenses
8.5.2. Interpretation and Reporting Tools
8.5.3. Cloud-Based Analysis Services
9. Targeted Genome Analysis Kits Market, by Application Area
9.1. Introduction
9.2. Oncology
9.2.1. Solid Tumor Oncology
9.2.2. Hematologic Oncology
9.2.3. Minimal Residual Disease Monitoring
9.3. Inherited and Rare Disease
9.4. Reproductive Health
9.4.1. Carrier Screening
9.4.2. Prenatal Testing
9.4.3. Preimplantation Genetic Testing
9.5. Pharmacogenomics
9.6. Infectious Disease
9.6.1. Pathogen Identification
9.6.2. Antimicrobial Resistance Profiling
9.6.3. Outbreak Surveillance
9.7. Immunology and Transplantation
9.8. Agriculture and Animal Health
9.9. Consumer Genomics and Wellness
10. Targeted Genome Analysis Kits Market, by End User
10.1. Introduction
10.2. Academic and Research Institutions
10.3. Hospitals and Clinical Laboratories
10.3.1. Hospital-Based Clinical Laboratories
10.3.2. Independent Reference Laboratories
10.4. Pharmaceutical and Biotechnology Companies
10.5. Contract Research Organizations
10.6. Government and Public Health Laboratories
10.7. Direct-To-Consumer Testing Companies
10.8. Industry Quality Control and Manufacturing Laboratories
11. Targeted Genome Analysis Kits Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Targeted Genome Analysis Kits Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Targeted Genome Analysis Kits Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 10x Genomics
15.2. Agilent Technologies, Inc.
15.3. BGI Genomics Co., Ltd.
15.4. Bio-Rad Laboratories
15.5. Eurofins Scientific SE
15.6. F. Hoffmann-La Roche Ltd.
15.7. Illumina, Inc.
15.8. Oxford Nanopore Technologies Ltd.
15.9. Pacific Biosciences of California, Inc.
15.10. PerkinElmer, Inc.
15.11. QIAGEN N.V.
15.12. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Targeted Genome Analysis Kits Market, Years Considered for the Study
FIGURE 2. Global Targeted Genome Analysis Kits Market, Research Design
FIGURE 3. Global Targeted Genome Analysis Kits Market, Research Framework
FIGURE 4. Global Targeted Genome Analysis Kits Market, Data Triangulation
FIGURE 5. Global Targeted Genome Analysis Kits Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Targeted Genome Analysis Kits Market Size, by Target Type, 2025 vs 2032 (%)
FIGURE 7. Global Targeted Genome Analysis Kits Market Size, by Target Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Targeted Genome Analysis Kits Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Targeted Genome Analysis Kits Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Targeted Genome Analysis Kits Market Size, by Application Area, 2025 vs 2032 (%)
FIGURE 11. Global Targeted Genome Analysis Kits Market Size, by Application Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Targeted Genome Analysis Kits Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Targeted Genome Analysis Kits Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Targeted Genome Analysis Kits Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Targeted Genome Analysis Kits Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Targeted Genome Analysis Kits Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Targeted Genome Analysis Kits Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Targeted Genome Analysis Kits Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Targeted Genome Analysis Kits Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Targeted Genome Analysis Kits Market Segmentation & Coverage
TABLE 2. Global Targeted Genome Analysis Kits Market Size, 2017-2032 (USD Million)
TABLE 3. Global Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 4. Global DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Germline DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Germline DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Germline DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Somatic DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Somatic DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Somatic DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Mitochondrial DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Mitochondrial DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Mitochondrial DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global mRNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global mRNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global mRNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Non-Coding RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Non-Coding RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Non-Coding RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Fusion Transcripts Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Fusion Transcripts Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Fusion Transcripts Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Epigenetic Marks Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Epigenetic Marks Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Epigenetic Marks Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global DNA Methylation Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global DNA Methylation Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global DNA Methylation Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Chromatin Accessibility Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Chromatin Accessibility Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Chromatin Accessibility Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 38. Global Complete Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Complete Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Complete Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Target Enrichment Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Target Enrichment Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Target Enrichment Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Integrated Library and Enrichment Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Integrated Library and Enrichment Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Integrated Library and Enrichment Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Panel-Only Reagent Sets Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Panel-Only Reagent Sets Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Panel-Only Reagent Sets Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Accessories and Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Accessories and Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Accessories and Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Indexing and Barcoding Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Indexing and Barcoding Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Indexing and Barcoding Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Reference Standards and Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Reference Standards and Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Reference Standards and Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Cleanup and Size Selection Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Cleanup and Size Selection Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Cleanup and Size Selection Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Software and Analytics Bundles Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Software and Analytics Bundles Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Software and Analytics Bundles Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Data Analysis Software Licenses Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Data Analysis Software Licenses Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Data Analysis Software Licenses Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Interpretation and Reporting Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Interpretation and Reporting Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Interpretation and Reporting Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Cloud-Based Analysis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Cloud-Based Analysis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Cloud-Based Analysis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 78. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Solid Tumor Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Solid Tumor Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Solid Tumor Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Hematologic Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Hematologic Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Hematologic Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Minimal Residual Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Minimal Residual Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Minimal Residual Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Inherited and Rare Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Inherited and Rare Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Inherited and Rare Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Reproductive Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Reproductive Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Reproductive Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Carrier Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Carrier Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Carrier Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Preimplantation Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Preimplantation Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Preimplantation Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Pathogen Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Pathogen Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Pathogen Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Antimicrobial Resistance Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Antimicrobial Resistance Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Antimicrobial Resistance Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Outbreak Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Outbreak Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Outbreak Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Immunology and Transplantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Immunology and Transplantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Immunology and Transplantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Agriculture and Animal Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Agriculture and Animal Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Agriculture and Animal Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Consumer Genomics and Wellness Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Consumer Genomics and Wellness Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Consumer Genomics and Wellness Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Global Academic and Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Academic and Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Academic and Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Hospitals and Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Hospitals and Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Hospitals and Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Hospital-Based Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Hospital-Based Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Hospital-Based Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Independent Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Independent Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Independent Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Pharmaceutical and Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Pharmaceutical and Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Pharmaceutical and Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Government and Public Health Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Government and Public Health Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Government and Public Health Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Direct-To-Consumer Testing Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Direct-To-Consumer Testing Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Direct-To-Consumer Testing Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Industry Quality Control and Manufacturing Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Industry Quality Control and Manufacturing Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Industry Quality Control and Manufacturing Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 173. North America Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. North America Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 175. North America Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 176. North America Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 177. North America Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 178. North America Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. North America Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 180. North America Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 181. North America Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 182. North America Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 183. North America Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 184. North America Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 185. North America Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 186. North America Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. North America Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 188. Latin America Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 189. Latin America Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 190. Latin America Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 191. Latin America Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 192. Latin America Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 193. Latin America Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. Latin America Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 195. Latin America Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 196. Latin America Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 197. Latin America Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 198. Latin America Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 199. Latin America Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 200. Latin America Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 201. Latin America Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Latin America Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 203. Europe Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Europe Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 205. Europe Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 206. Europe Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 207. Europe Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 208. Europe Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Europe Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 210. Europe Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 211. Europe Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 212. Europe Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 213. Europe Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 214. Europe Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 215. Europe Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 216. Europe Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Europe Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 218. Middle East Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Middle East Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 220. Middle East Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 221. Middle East Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 222. Middle East Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 223. Middle East Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Middle East Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 225. Middle East Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 226. Middle East Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 227. Middle East Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 228. Middle East Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. Middle East Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 230. Middle East Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 231. Middle East Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Middle East Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 233. Africa Targeted Genome Analysis Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Africa Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 235. Africa Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 236. Africa Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 237. Africa Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 238. Africa Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Africa Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 240. Africa Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 241. Africa Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 242. Africa Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 243. Africa Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 244. Africa Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 245. Africa Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 246. Africa Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Africa Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 248. Global Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. ASEAN Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. ASEAN Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 251. ASEAN Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 252. ASEAN Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 253. ASEAN Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 254. ASEAN Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. ASEAN Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 256. ASEAN Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 257. ASEAN Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 258. ASEAN Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 259. ASEAN Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 260. ASEAN Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 261. ASEAN Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 262. ASEAN Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. ASEAN Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 264. GCC Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 265. GCC Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 266. GCC Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 267. GCC Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 268. GCC Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 269. GCC Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. GCC Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 271. GCC Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 272. GCC Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 273. GCC Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 274. GCC Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 275. GCC Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 276. GCC Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 277. GCC Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. GCC Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 279. European Union Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 280. European Union Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 281. European Union Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 282. European Union Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 283. European Union Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 284. European Union Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 285. European Union Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 286. European Union Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 287. European Union Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 288. European Union Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 289. European Union Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 290. European Union Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 291. European Union Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 292. European Union Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. European Union Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 294. BRICS Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 295. BRICS Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 296. BRICS Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 297. BRICS Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 298. BRICS Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 299. BRICS Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 300. BRICS Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 301. BRICS Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 302. BRICS Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 303. BRICS Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 304. BRICS Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 305. BRICS Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 306. BRICS Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 307. BRICS Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. BRICS Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 309. G7 Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. G7 Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 311. G7 Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 312. G7 Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 313. G7 Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 314. G7 Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 315. G7 Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 316. G7 Targeted Genome Analysis Kits Market Size, by Accessories and Controls, 2017-2032 (USD Million)
TABLE 317. G7 Targeted Genome Analysis Kits Market Size, by Software and Analytics Bundles, 2017-2032 (USD Million)
TABLE 318. G7 Targeted Genome Analysis Kits Market Size, by Application Area, 2017-2032 (USD Million)
TABLE 319. G7 Targeted Genome Analysis Kits Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. G7 Targeted Genome Analysis Kits Market Size, by Reproductive Health, 2017-2032 (USD Million)
TABLE 321. G7 Targeted Genome Analysis Kits Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 322. G7 Targeted Genome Analysis Kits Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. G7 Targeted Genome Analysis Kits Market Size, by Hospitals and Clinical Laboratories, 2017-2032 (USD Million)
TABLE 324. NATO Targeted Genome Analysis Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. NATO Targeted Genome Analysis Kits Market Size, by Target Type, 2017-2032 (USD Million)
TABLE 326. NATO Targeted Genome Analysis Kits Market Size, by DNA, 2017-2032 (USD Million)
TABLE 327. NATO Targeted Genome Analysis Kits Market Size, by RNA, 2017-2032 (USD Million)
TABLE 328. NATO Targeted Genome Analysis Kits Market Size, by Epigenetic Marks, 2017-2032 (USD Million)
TABLE 329. NATO Targeted Genome Analysis Kits Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 330. NATO Targeted Genome Analysis Kits Market Size, by Complete Kits, 2017-2032 (USD Million)
TABLE 331. NATO Targeted Genom

Companies Mentioned

  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032 - Product Image

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
DNA Library Prep Kits for Whole-Genome Sequencing Market - Global Forecast 2026-2032 - Product Image

DNA Library Prep Kits for Whole-Genome Sequencing Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Whole Genome Amplification (WGA) - Global Strategic Business Report - Product Image

Whole Genome Amplification (WGA) - Global Strategic Business Report

  • Report
  • 396 Pages
  • Global
From
Single-Cell Genome Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Single-Cell Genome Sequencing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Genome-Wide Association Studies Market Report 2026 - Product Image

Genome-Wide Association Studies Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.